MeiraGTx Holdings PLC MGTX:NASDAQ

Last Price$6.38NASDAQ Previous Close - Last Trade as of 12:59PM ET 11/25/22

Today's Change+0.005(0.08%)
Bid (Size)$6.36 (3)
Ask (Size)$7.60 (7)
Day Low / High$6.30 - 6.59
Volume47.5 K
  • Latest Stories
  • Commentary and Analysis
MeiraGTx Holdings to Formally Unveil Gene Therapy Manufacturing Facility in Ireland
3:30AM ET 9/16/2022 MT Newswires

MeiraGTx Holdings (MGTX) said Friday it will formally unveil a gene therapy manufacturing facility in Shannon, Ireland, on Friday. The facility, which came...

--Chardan Research Trims MeiraGTx Holdings Price Target to $46 From $47, Maintains Buy Rating
10:27AM ET 8/12/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

MeiraGTx's Q2 Net Loss Per Diluted Share Widens; Expects Sufficient Capital Through Q4 2024
9:32AM ET 8/11/2022 MT Newswires

MeiraGTx Holdings (MGTX) reported a Q2 net loss Thursday of $0.76 per diluted share, wider than its loss of $0.46 a year earlier. Four analysts polled by...

MeiraGTx Says it Gets $100 Million Term Loan From Perceptive Advisors; MeiraGTx Shares Rise
11:18AM ET 8/03/2022 MT Newswires

MeiraGTx Holdings (MGTX) said Wednesday it has obtained a term loan from Perceptive Advisors for up to $100 million, including $75 million upon closing....

MeiraGTx Sees Positive Data From Phase 1/2 Trial of Botaretigene Sparoparvovec for X-Linked Retinitis Pigmentosa Patients
8:11AM ET 6/28/2022 MT Newswires

MeiraGTx Holdings (MGTX) said Tuesday it has seen encouraging data from a phase 1/2 clinical study of botaretigene sparoparvovec to treat patients with...

--Chardan Lowers MeiraGTx Holdings's Price Target to $46 From $55, Maintains Buy Rating
10:47AM ET 5/13/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Barclays Lowers MeiraGTx Holdings's Price Target to $18 From $32, Maintains Overweight Rating
10:47AM ET 5/13/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Piper Sandler Adjusts MeiraGTx Holdings' Price Target to $30 From $40, Reiterates Overweight Rating
5:06AM ET 5/13/2022 MT Newswires

MeiraGTx Holdings (MGTX) has an average rating of buy and price targets ranging from $18 to $55, according to analysts polled by Capital IQ. (MT Newswires...

MeiraGTx Holdings 2021 Net Loss Widens; Expects Sufficient Capital Through Q2 2023
8:41AM ET 3/10/2022 MT Newswires

MeiraGTx Holdings (MGTX) on Thursday reported a full-year 2021 net loss of $1.80 per diluted share, widening from a loss of $1.54 per share in 2020....

MeiraGTx Gets $30 Million Milestone Payment from Janssen Pharmaceuticals for Retinitis Pigmentosa Trial
10:32AM ET 1/27/2022 MT Newswires

MeiraGTx Holdings (MGTX) said Thursday it has received $30 million from Johnson & Johnson's (JNJ) Janssen Pharmaceuticals for achieving a clinical...